Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

On glioblastoma and the search for a cure: where do we stand?

Bianco J, Bastiancich C, Jankovski A, des Rieux A, Préat V, Danhier F.

Cell Mol Life Sci. 2017 Jul;74(13):2451-2466. doi: 10.1007/s00018-017-2483-3. Epub 2017 Feb 17. Review.

PMID:
28210785
2.

Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.

Nduom EK, Hadjipanayis CG, Van Meir EG.

Cancer J. 2012 Jan-Feb;18(1):100-6. doi: 10.1097/PPO.0b013e3182452e0d. Review.

3.

Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.

Miranda A, Blanco-Prieto M, Sousa J, Pais A, Vitorino C.

Int J Pharm. 2017 Oct 5;531(1):372-388. doi: 10.1016/j.ijpharm.2017.07.056. Epub 2017 Jul 27. Review.

PMID:
28755993
4.

Frontiers in targeting glioma stem cells.

Frosina G.

Eur J Cancer. 2011 Mar;47(4):496-507. doi: 10.1016/j.ejca.2010.11.017. Epub 2010 Dec 22. Review.

PMID:
21185169
5.

Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.

Kim SS, Harford JB, Pirollo KF, Chang EH.

Biochem Biophys Res Commun. 2015 Dec 18;468(3):485-9. doi: 10.1016/j.bbrc.2015.06.137. Epub 2015 Jun 24. Review.

6.

Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.

Huang Z, Cheng L, Guryanova OA, Wu Q, Bao S.

Protein Cell. 2010 Jul;1(7):638-55. doi: 10.1007/s13238-010-0078-y. Epub 2010 Jul 29. Review.

7.

Understanding glioma stem cells: rationale, clinical relevance and therapeutic strategies.

Ahmed AU, Auffinger B, Lesniak MS.

Expert Rev Neurother. 2013 May;13(5):545-55. doi: 10.1586/ern.13.42. Review.

8.

Novel cellular and post-genomic technologies in the treatment of glioblastoma multiforme (Review).

Bryukhovetskiy I, Bryukhovetskiy A, Khotimchenko Y, Mischenko P.

Oncol Rep. 2016 Feb;35(2):639-48. doi: 10.3892/or.2015.4404. Epub 2015 Nov 6. Review.

PMID:
26548844
9.

Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.

Kesari S.

Semin Oncol. 2011 Dec;38 Suppl 4:S2-10. doi: 10.1053/j.seminoncol.2011.09.005. Review.

PMID:
22078644
10.

Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.

Song WS, Yang YP, Huang CS, Lu KH, Liu WH, Wu WW, Lee YY, Lo WL, Lee SD, Chen YW, Huang PI, Chen MT.

J Chin Med Assoc. 2016 Oct;79(10):538-45. doi: 10.1016/j.jcma.2016.03.010. Epub 2016 Aug 13.

11.

Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications.

Yang L, Lin C, Wang L, Guo H, Wang X.

Exp Cell Res. 2012 Nov 15;318(19):2417-26. doi: 10.1016/j.yexcr.2012.07.017. Epub 2012 Aug 13. Review.

PMID:
22906859
12.

The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications.

Persano L, Rampazzo E, Della Puppa A, Pistollato F, Basso G.

ScientificWorldJournal. 2011;11:1829-41. doi: 10.1100/2011/736480. Epub 2011 Oct 23. Review.

13.

Glioblastoma cancer stem cells: Biomarker and therapeutic advances.

Pointer KB, Clark PA, Zorniak M, Alrfaei BM, Kuo JS.

Neurochem Int. 2014 May;71:1-7. doi: 10.1016/j.neuint.2014.03.005. Epub 2014 Mar 19. Review.

14.

FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.

Lee Y, Kim KH, Kim DG, Cho HJ, Kim Y, Rheey J, Shin K, Seo YJ, Choi YS, Lee JI, Lee J, Joo KM, Nam DH.

PLoS One. 2015 Oct 7;10(10):e0137703. doi: 10.1371/journal.pone.0137703. eCollection 2015.

15.

Current vaccine trials in glioblastoma: a review.

Xu LW, Chow KK, Lim M, Li G.

J Immunol Res. 2014;2014:796856. doi: 10.1155/2014/796856. Epub 2014 Apr 3. Review.

16.

Understanding the role of tumor stem cells in glioblastoma multiforme: a review article.

Fatoo A, Nanaszko MJ, Allen BB, Mok CL, Bukanova EN, Beyene R, Moliterno JA, Boockvar JA.

J Neurooncol. 2011 Jul;103(3):397-408. doi: 10.1007/s11060-010-0406-3. Epub 2010 Sep 18. Review.

PMID:
20853017
17.

Targeting glioblastoma cancer stem cells: the next great hope?

Khan IS, Ehtesham M.

Neurosurg Focus. 2014 Dec;37(6):E7. Review.

PMID:
25581936
18.

Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.

Wakimoto H, Kesari S, Farrell CJ, Curry WT Jr, Zaupa C, Aghi M, Kuroda T, Stemmer-Rachamimov A, Shah K, Liu TC, Jeyaretna DS, Debasitis J, Pruszak J, Martuza RL, Rabkin SD.

Cancer Res. 2009 Apr 15;69(8):3472-81. doi: 10.1158/0008-5472.CAN-08-3886. Epub 2009 Apr 7.

19.

Immunotherapy targeting glioma stem cells--insights and perspectives.

Li Z, Lee JW, Mukherjee D, Ji J, Jeswani SP, Black KL, Yu JS.

Expert Opin Biol Ther. 2012 Feb;12(2):165-78. doi: 10.1517/14712598.2012.648180. Epub 2011 Dec 26. Review.

PMID:
22200324
20.

Heterogeneity of cancer-initiating cells within glioblastoma.

Binda E, Visioli A, Reynolds B, Vescovi AL.

Front Biosci (Schol Ed). 2012 Jun 1;4:1235-48. Review.

PMID:
22652868

Supplemental Content

Support Center